On July 1, 2026, XMax Inc. entered into Securities Purchase Agreements for a private placement of 434,600 shares of common stock to non-U.S. investors. The shares were sold at a price of $8.454 per share, resulting in total aggregate proceeds of $3,674,108.40. The purchasers are subject to an 18-month lock-up period prohibiting the sale or transfer of the shares without company consent. The transaction was completed under Regulation S. XMax Inc. operates in the healthcare industry, providing medical device and equipment solutions.
